Madsen, E.A.; Thorlacius-Ussing, J.; Nissen, N.I.; Jensen, C.; Chen, I.M.; Johansen, J.S.; Diab, H.M.H.; Jørgensen, L.N.; Hansen, C.P.; Karsdal, M.A.;
et al. Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer. Cells 2022, 11, 3763.
https://doi.org/10.3390/cells11233763
AMA Style
Madsen EA, Thorlacius-Ussing J, Nissen NI, Jensen C, Chen IM, Johansen JS, Diab HMH, Jørgensen LN, Hansen CP, Karsdal MA,
et al. Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer. Cells. 2022; 11(23):3763.
https://doi.org/10.3390/cells11233763
Chicago/Turabian Style
Madsen, Emilie A., Jeppe Thorlacius-Ussing, Neel I. Nissen, Christina Jensen, Inna M. Chen, Julia S. Johansen, Hadi M. H. Diab, Lars N. Jørgensen, Carsten P. Hansen, Morten A. Karsdal,
and et al. 2022. "Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer" Cells 11, no. 23: 3763.
https://doi.org/10.3390/cells11233763
APA Style
Madsen, E. A., Thorlacius-Ussing, J., Nissen, N. I., Jensen, C., Chen, I. M., Johansen, J. S., Diab, H. M. H., Jørgensen, L. N., Hansen, C. P., Karsdal, M. A., & Willumsen, N.
(2022). Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer. Cells, 11(23), 3763.
https://doi.org/10.3390/cells11233763